Dachaigh › Leukemia › North Carolina › Durham
Sgrùdaidhean clionaigeach Leukemia ann an Durham, NC
Tha 13 sgrùdaidhean airson Leukemia a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
A’ fastadhÌre 3
- Quetzal Site 27, Chapel Hill · 10 mìle air falbh
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
A’ fastadhÌre 1/2
- Duke University Medical Center, Durham
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A’ fastadhÌre 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 mìle air falbh
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
A’ fastadh
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mìle air falbh
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mìle air falbh
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
A’ fastadhFàilte do shaor-thoilich fhallain
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
A Study of Revumenib and Mezigdomide in People With Leukemia
A’ fastadhÌre 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 mìle air falbh
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
A’ fastadhÌre 2/3
- Duke University, Durham
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
A’ fastadhÌre 1
- Duke Blood Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mìle air falbh
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
A’ fastadhSgrùdadh amharc
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
A’ fastadhÌre 2
- Durham VA Medical Center, Durham, NC, Durham
Sgrùdaidhean Leukemia ann am bailtean eile
- Houston, TX28 sgrùdaidhean
- Boston, MA25 sgrùdaidhean
- New York City, NY19 sgrùdaidhean
- Los Angeles, CA16 sgrùdaidhean
- Chicago, IL16 sgrùdaidhean
- Baldwin Park, CA12 sgrùdaidhean
- Nashville, TN12 sgrùdaidhean
- Columbus, OH12 sgrùdaidhean
- Philadelphia, PA12 sgrùdaidhean
- Milwaukee, WI11 sgrùdadh
- Atlanta, GA11 sgrùdadh
- Seattle, WA11 sgrùdadh
Sgrùdaidhean eile ann an Durham
- Aillse a' bhroilleach63 sgrùdaidhean
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag39 sgrùdaidhean
- Myeloma iomaill37 sgrùdaidhean
- Ailse metastatach33 sgrùdaidhean
- Leukemia myeloid geur33 sgrùdaidhean
- Ailseachadh nan Sgamhan32 sgrùdaidhean
- Aillse Prostata32 sgrùdaidhean
- Aillse colorectal28 sgrùdaidhean
- Leukemia Lymphocytic Cronach27 sgrùdaidhean
- Cancer Ovarian27 sgrùdaidhean
- Fàilligeadh a' Chridhe26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.